The rising popularity in GLP-1 agonists for diabetes has led to a debate about delivery routes : transdermal systems versus tablets . Traditionally , GLP-1 drugs were only available in pill form, but the https://cyruscyvh511265.worldblogged.com/47345698/glp-1-skin-applications-vs-pills-is-suitable-for-the-patient